'Terrible dilemma': Toobin on FDA's Alzheimer treatment approval

Name: 'Terrible dilemma': Toobin on FDA's Alzheimer treatment approval
Uploaded: 2021-09-27T12:10:12+00:00
Duration: P108S
Description: CNN’s Jeffrey Toobin weighs in on the FDA’s approval of a new Alzheimer’s drug in June despite the FDA’s advisory committee concluding there wasn’t

Credit: Bleacher Report AOL

Duration: 01:48s 27 Sep 2021 0 shares 1 views

'Terrible dilemma': Toobin on FDA's Alzheimer treatment approval

CNN’s Jeffrey Toobin weighs in on the FDA’s approval of a new Alzheimer’s drug in June despite the FDA’s advisory committee concluding there wasn’t enough evidence to support the effectiveness of the treatment.

'Terrible dilemma': Toobin on FDA's Alzheimer treatment approval

You might like